7H-pyrrolopyrimidine derivatives

Details for Australian Patent Application No. 2005212832 (hide)

Owner Novartis AG

Inventors Caravatti, Giorgio; Vaupel, Andrea

Agent Davies Collison Cave

Pub. Number AU-B-2005212832

PCT Pub. Number WO2005/077951

Priority 0403606.7 18.02.04 GB

Filing date 17 February 2005

Wipo publication date 25 August 2005

Acceptance publication date 5 November 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/077951 Priority application(s): WO2005/077951

5 November 2009 Application Accepted

  Published as AU-B-2005212832

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005212833-Pyrazoline derivatives useful for the treatment of cancer

2005212831-Identification of SNPs associated with hyperlipidemia, dyslipidemia and defective carbohydrate metabolism